Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rapport Therapeutics Inc....

    NASDAQ: RAPP · Real-Time Price · USD
    14.66
    -0.28 (-1.87%)
    At close: Aug 15, 2025, 3:59 PM
    14.57
    -0.61%
    After-hours: Aug 15, 2025, 05:51 PM EDT

    Rapport Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 n/a n/a 720K n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 252K 244K n/a 219K 208K 152K 76K n/a 21K 15K
    Gross Profit
    		 -252K -244K 360K -219K -208K -152K -76K n/a -21K -15K
    Operating Income
    		 -29.5M -27.11M -23.52M -21.64M -20.8M -17.09M -14.79M -9.56M -6.63M -5.19M
    Interest Income
    		 2.76M 3.04M 3.54M 4.1M 2.68M 1.81M 1.38M 856K 221K 75K
    Pretax Income
    		 -26.73M -24.06M -19.98M -17.54M -18.12M -22.67M -13.51M -8.71M -6.41M -6.15M
    Net Income
    		 -26.73M -24.06M -19.98M -17.54M -18.12M -22.67M -13.52M -8.71M -6.41M -6.15M
    Selling & General & Admin
    		 6.82M 7.54M 6.32M 6.1M 4.9M 4.44M 2.92M 1.98M 1.89M 1.28M
    Research & Development
    		 22.68M 19.57M 17.2M 15.54M 15.69M 12.5M 11.8M 7.58M 4.72M 3.9M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 29.5M 27.11M 23.52M 21.64M 20.59M 16.94M 14.72M 9.56M 6.61M 5.18M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a -208K -152K -76K n/a -21K -15K
    Cost & Expenses
    		 29.5M 27.11M 23.52M 21.64M 20.8M 17.09M 14.79M 9.56M 6.63M 5.19M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a 6K 1K 2K 1K
    Shares Outstanding (Basic)
    		 354.45M 192.88M 192.88M 191.71M 201.17M 194.57M 180.79M 190.98M 201.17M 194.57M
    Shares Outstanding (Diluted)
    		 354.45M 192.88M 192.88M 191.71M 201.17M 194.57M 180.79M 190.98M 201.17M 194.57M
    EPS (Basic)
    		 -0.75 -0.12 -0.1 -0.09 -0.09 -0.12 -0.07 -0.05 -0.03 -0.03
    EPS (Diluted)
    		 -0.75 -0.12 -0.1 -0.09 -0.09 -0.12 -0.07 -0.05 -0.03 -0.03
    EBITDA
    		 -29.5M -27.11M -23.26M -21.42M -20.59M -16.94M -13.34M -9.54M -6.61M -5.18M
    EBIT
    		 -26.73M -24.06M -23.52M -21.64M -20.8M -17.09M -13.39M -9.56M -6.63M -5.19M
    Depreciation & Amortization
    		 n/a 244K 260K 219K 208K 152K 53K 23K 21K 15K

    Add to Watchlist